These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

818 related items for PubMed ID: 22154620

  • 1. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y, Liu L.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):640-65. PubMed ID: 22154620
    [Abstract] [Full Text] [Related]

  • 2. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 15; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 3. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D, Combs-Bachmann RE, Hussey AM, McCarron ST, McCarthy DS, Chambers JJ.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):666-85. PubMed ID: 22138074
    [Abstract] [Full Text] [Related]

  • 4. Strategies to improve drug delivery across the blood-brain barrier.
    de Boer AG, Gaillard PJ.
    Clin Pharmacokinet; 2007 May 15; 46(7):553-76. PubMed ID: 17596102
    [Abstract] [Full Text] [Related]

  • 5. Drug targeting to the brain.
    de Boer AG, Gaillard PJ.
    Annu Rev Pharmacol Toxicol; 2007 May 15; 47():323-55. PubMed ID: 16961459
    [Abstract] [Full Text] [Related]

  • 6. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
    Gaillard PJ, de Boer AG.
    Methods Mol Biol; 2008 May 15; 437():161-75. PubMed ID: 18369968
    [Abstract] [Full Text] [Related]

  • 7. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
    Tucker IG, Yang L, Mujoo H.
    J Microencapsul; 2012 May 15; 29(5):475-86. PubMed ID: 22563886
    [Abstract] [Full Text] [Related]

  • 8. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK.
    Nanomedicine (Lond); 2012 Aug 15; 7(8):1225-33. PubMed ID: 22931448
    [Abstract] [Full Text] [Related]

  • 9. Learning from our failures in blood-brain permeability: what can be done for new drug discovery?
    Martel S.
    Expert Opin Drug Discov; 2015 Mar 15; 10(3):207-11. PubMed ID: 25658294
    [Abstract] [Full Text] [Related]

  • 10. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K, Gorki K, Jaroszek H, Jarzabek K, Gabryel B, Okopien B.
    CNS Neurol Disord Drug Targets; 2013 Dec 15; 12(8):1271-85. PubMed ID: 24040789
    [Abstract] [Full Text] [Related]

  • 11. Blood-brain barrier transport of drugs for the treatment of brain diseases.
    Gabathuler R.
    CNS Neurol Disord Drug Targets; 2009 Jun 15; 8(3):195-204. PubMed ID: 19601817
    [Abstract] [Full Text] [Related]

  • 12. Strategy for effective brain drug delivery.
    Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.
    Eur J Pharm Sci; 2010 Aug 11; 40(5):385-403. PubMed ID: 20497904
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS, Ramaiyan V, Sukumaran SK.
    Inflammopharmacology; 2018 Jun 11; 26(3):675-684. PubMed ID: 29582240
    [Abstract] [Full Text] [Related]

  • 14. Molecular Trojan horses for blood-brain barrier drug delivery.
    Pardridge WM.
    Discov Med; 2006 Aug 11; 6(34):139-43. PubMed ID: 17234133
    [Abstract] [Full Text] [Related]

  • 15. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.
    Gabathuler R.
    Neurobiol Dis; 2010 Jan 11; 37(1):48-57. PubMed ID: 19664710
    [Abstract] [Full Text] [Related]

  • 16. Blood-brain barrier: an impediment to neuropharmaceuticals.
    Henderson JT, Piquette-Miller M.
    Clin Pharmacol Ther; 2015 Apr 11; 97(4):308-13. PubMed ID: 25670372
    [Abstract] [Full Text] [Related]

  • 17. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA.
    Surg Neurol; 2007 Feb 11; 67(2):113-6. PubMed ID: 17254859
    [Abstract] [Full Text] [Related]

  • 18. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S, Gelperina S, Kreuter J.
    J Control Release; 2012 Jul 20; 161(2):264-73. PubMed ID: 21872624
    [Abstract] [Full Text] [Related]

  • 19. Blood-brain barrier drug targeting: the future of brain drug development.
    Pardridge WM.
    Mol Interv; 2003 Mar 20; 3(2):90-105, 51. PubMed ID: 14993430
    [Abstract] [Full Text] [Related]

  • 20. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R, Decleves X, Scherrmann JM.
    Curr Drug Metab; 2013 Jan 20; 14(1):120-36. PubMed ID: 23215812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.